Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report)'s share price was down 6.1% during trading on Monday . The company traded as low as $2.83 and last traded at $2.84. Approximately 2,917,560 shares traded hands during trading, a decline of 56% from the average daily volume of 6,646,314 shares. The stock had previously closed at $3.02.
Analyst Ratings Changes
Separately, Canaccord Genuity Group lifted their price target on Clover Health Investments from $4.20 to $4.50 and gave the stock a "buy" rating in a report on Monday, March 3rd.
Check Out Our Latest Stock Analysis on CLOV
Clover Health Investments Stock Down 6.1%
The company has a market capitalization of $1.44 billion, a PE ratio of -56.70 and a beta of 1.92. The company has a 50-day moving average price of $3.30 and a two-hundred day moving average price of $3.62.
Clover Health Investments (NASDAQ:CLOV - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.12. Clover Health Investments had a negative return on equity of 7.42% and a negative net margin of 1.69%. The company had revenue of $462.33 million during the quarter, compared to analysts' expectations of $466.93 million. As a group, equities analysts anticipate that Clover Health Investments, Corp. will post -0.12 EPS for the current fiscal year.
Institutional Trading of Clover Health Investments
A number of hedge funds have recently bought and sold shares of the company. Y Intercept Hong Kong Ltd purchased a new stake in shares of Clover Health Investments in the 4th quarter valued at $135,000. Arizona State Retirement System boosted its stake in shares of Clover Health Investments by 6.3% in the 4th quarter. Arizona State Retirement System now owns 118,265 shares of the company's stock valued at $373,000 after purchasing an additional 6,990 shares in the last quarter. Swiss National Bank boosted its stake in shares of Clover Health Investments by 6.3% in the 4th quarter. Swiss National Bank now owns 802,100 shares of the company's stock valued at $2,527,000 after purchasing an additional 47,700 shares in the last quarter. Counterpoint Mutual Funds LLC boosted its stake in shares of Clover Health Investments by 153.0% in the 4th quarter. Counterpoint Mutual Funds LLC now owns 233,392 shares of the company's stock valued at $735,000 after purchasing an additional 141,148 shares in the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in shares of Clover Health Investments in the 4th quarter valued at $2,769,000. Institutional investors own 19.77% of the company's stock.
About Clover Health Investments
(
Get Free Report)
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clover Health Investments, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.
While Clover Health Investments currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.